We found that lncRNA NR2F1-AS1 and lncRNA AC010168.2 were independent prognostic biomarkers and used for constructing a lncRNA signature to predict the prognosis of bladder cancer. This evidence concerns the gene NR2F1 and urinary bladder cancer.